Previous Article | Next Article ![]()
Journal of Clinical Microbiology, March 2000, p. 1053-1057, Vol. 38, No. 3
Sir Albert Sakzewski Virus Research Centre,
The Royal Children's Hospital, Herston, Brisbane
4029,1 and Department of Microbiology
and Parasitology, The University of Queensland, St. Lucia, Brisbane
4072,2 Australia
Received 7 September 1999/Returned for modification 2 December
1999/Accepted 24 December 1999
We describe the development of a capture enzyme-linked
immunosorbent assay for the detection of the dengue virus nonstructural protein NS1. The assay employs rabbit polyclonal and monoclonal antibodies as the capture and detection antibodies, respectively. Immunoaffinity-purified NS1 derived from dengue 2 virus-infected cells
was used as a standard to establish a detection sensitivity of
approximately 4 ng/ml for an assay employing monoclonal antibodies recognizing a dengue 2 serotype-specific epitope. A number of serotype
cross-reactive monoclonal antibodies were also shown to be suitable
probes for the detection of NS1 expressed by the remaining three dengue
virus serotypes. Examination of clinical samples demonstrated that the
assay was able to detect NS1 with minimal interference from serum
components at the test dilutions routinely used, suggesting that
it could form the basis of a useful additional diagnostic test for
dengue virus infection. Furthermore, quantitation of NS1 levels in
patient sera may prove to be a valuable surrogate marker for viremia.
Surprisingly high levels of NS1, as much as 15 µg/ml, were found in
acute-phase sera taken from some of the patients experiencing
serologically confirmed dengue 2 virus secondary infections but was not
detected in the convalescent sera of these patients. In contrast, NS1
could not be detected in either acute-phase or convalescent serum
samples taken from patients with serologically confirmed primary
infection. The presence of high levels of secreted NS1 in the
sera of patients experiencing secondary dengue virus infections, and in
the context of an anamnestic antibody response, suggests that NS1 may
contribute significantly to the formation of the circulating immune
complexes that are suspected to play an important role in the
pathogenesis of severe dengue disease.
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
An Antigen Capture Enzyme-Linked Immunosorbent
Assay Reveals High Levels of the Dengue Virus Protein NS1 in the
Sera of Infected Patients
*
Corresponding author. Mailing address: Sir Albert
Sakzewski Virus Research Centre, Royal Children's Hospital, Brisbane
4029, Australia. Phone: 61 7 3253 8718. Fax: 61 7 3253 1401. E-mail: p.young{at}mailbox.uq.edu.au.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|